{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["RAW 264.7 cells", "cannabichromene", "cytokines", "inflammation", "pink pepper"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38068603", "DateRevised": {"Year": "2023", "Month": "12", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "25"}], "Language": ["eng"], "ELocationID": ["3966", "10.3390/plants12233966"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "12", "Issue": "23", "PubDate": {"Year": "2023", "Month": "Nov", "Day": "25"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "In Vitro and In Vivo Anti-Inflammatory Potential of Cannabichromene Isolated from Hemp.", "Abstract": {"AbstractText": ["Cannabichromene (CBC), a non-psychoactive cannabinoid found in <i>Cannabis sativa</i>, has recently been shown to possess several medicinal properties. However, how CBC produces anti-inflammatory effects and the mechanisms of this remain poorly studied. Therefore, we extracted and purified the CBC from the <i>Cannabis sativa</i> cv. pink pepper (hemp cultivar). The efficacy of CBC in reducing inflammation in RAW 264.7 macrophages and a \u03bb-carrageenan-induced mouse model was then evaluated. CBC had no cytotoxicity up to a concentration of 20 \u03bcM and inhibited nitric oxide production by approximately 50% at a concentration of 20 \u03bcM. In addition, CBC treatment significantly inhibited causes of inflammation such as inducible nitric oxide synthase (iNOS), interleukin-1\u03b2 (IL-1\u03b2), IL-6, and tumor necrosis factor-\u03b1 (TNF-\u03b1) at both the mRNA and protein levels. Moreover, CBC suppressed LPS-stimulated inflammation in RAW 264.7 cells by downregulating the nuclear factor kappa B (NF-kB) and mitogen-activated protein kinase pathways (MAPK). Furthermore, our in vivo experiments confirmed that the \u03bb-carrageenan-induced increase in the levels of the cytokines iNOS, IL-1\u03b2, and IL-6 was abrogated following treatment with CBC. Therefore, CBC has potential anti-inflammatory effects and may be useful for preventing or treating inflammation."]}, "AuthorList": [{"Identifier": ["0000-0002-0517-7433"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chuncheon Bioindustry Foundation, Chuncheon 24232, Republic of Korea."}], "LastName": "Hong", "ForeName": "Min", "Initials": "M"}, {"Identifier": ["0000-0002-8907-5329"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chuncheon Bioindustry Foundation, Chuncheon 24232, Republic of Korea."}], "LastName": "Kim", "ForeName": "Jong-Hui", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chuncheon Bioindustry Foundation, Chuncheon 24232, Republic of Korea."}], "LastName": "Han", "ForeName": "Joon-Hee", "Initials": "JH"}, {"Identifier": ["0000-0002-1949-0156"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bio-Health Convergence, Graduate School, Kangwon National University, Chuncheon 24341, Republic of Korea."}], "LastName": "Ryu", "ForeName": "Byeong-Ryeol", "Initials": "BR"}, {"Identifier": ["0000-0003-4167-5824"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bio-Health Convergence, Graduate School, Kangwon National University, Chuncheon 24341, Republic of Korea."}], "LastName": "Lim", "ForeName": "Young-Seok", "Initials": "YS"}, {"Identifier": ["0000-0002-5668-3432"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bio-Health Convergence, Graduate School, Kangwon National University, Chuncheon 24341, Republic of Korea."}], "LastName": "Lim", "ForeName": "Jung-Dae", "Initials": "JD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Cannabis Research, Colorado State University-Pueblo, Pueblo, CO 81001, USA."}], "LastName": "Park", "ForeName": "Sang-Hyuck", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chuncheon Bioindustry Foundation, Chuncheon 24232, Republic of Korea."}], "LastName": "Kim", "ForeName": "Chang-Hyeug", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chuncheon Bioindustry Foundation, Chuncheon 24232, Republic of Korea."}], "LastName": "Lee", "ForeName": "Soo-Ung", "Initials": "SU"}, {"Identifier": ["0000-0002-2250-9444"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chuncheon Bioindustry Foundation, Chuncheon 24232, Republic of Korea."}], "LastName": "Kwon", "ForeName": "Tae-Hyung", "Initials": "TH"}], "GrantList": [{"GrantID": "MSIT, 2021-DD-UP-0379", "Agency": "Ministry of Science and ICT", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Anderson L.L., Ametovski A., Lin Luo J., Everett-Morgan D., McGregor I.S., Banister S.D., Arnold J.C. Cannabichromene, related phytocannabinoids, and 5-fluoro-cannabichromene have anticonvulsant properties in a mouse model of Dravet Syndrome. ACS Chem. Neurosci. 2021;12:330\u2013339. doi: 10.1021/acschemneuro.0c00677.", "ArticleIdList": ["10.1021/acschemneuro.0c00677", "33395525"]}, {"Citation": "Yang Y., Yu T., Jang H.J., Byeon S.E., Song S.Y., Lee B.H., Rhee M.H., Kim T.W., Lee J., Hong S., et al. In vitro and in vivo anti-inflammatory activities of Polygonum hydropiper methanol extract. J. Ethnopharmacol. 2012;139:616\u2013625. doi: 10.1016/j.jep.2011.12.003.", "ArticleIdList": ["10.1016/j.jep.2011.12.003", "22182430"]}, {"Citation": "Sherwood E.R., Toliver-Kinsky T. Mechanisms of the inflammatory response. Best Pract. Res. Clin. Anaesthesiol. 2004;18:385\u2013405. doi: 10.1016/j.bpa.2003.12.002.", "ArticleIdList": ["10.1016/j.bpa.2003.12.002", "15212335"]}, {"Citation": "Chen L., Deng H., Cui H., Fang J., Zuo Z., Deng J., Li Y., Wang X., Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9:7204\u20137218. doi: 10.18632/oncotarget.23208.", "ArticleIdList": ["10.18632/oncotarget.23208", "PMC5805548", "29467962"]}, {"Citation": "Kim E.O., Min K.J., Kwon T.K., Um B.H., Moreau R.A., Choi S.W. Anti-inflammatory activity of hydroxycinnamic acid derivatives isolated from corn bran in lipopolysaccharide-stimulated Raw 264.7 macrophages. Food Chem. Toxicol. 2012;50:1309\u20131316. doi: 10.1016/j.fct.2012.02.011.", "ArticleIdList": ["10.1016/j.fct.2012.02.011", "22366099"]}, {"Citation": "Yu T., Lee Y.J., Jang H.J., Kim A.R., Hong S., Kim T.W., Kim M.Y., Lee J., Lee Y.G., Cho J.Y. Anti-inflammatory activity of Sorbus commixta water extract and its molecular inhibitory mechanism. J. Ethnopharmacol. 2011;134:493\u2013500. doi: 10.1016/j.jep.2010.12.032.", "ArticleIdList": ["10.1016/j.jep.2010.12.032", "21195756"]}, {"Citation": "Reddy D.B., Reddanna P. Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-\u03baB and MAPK activation in RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 2009;381:112\u2013117. doi: 10.1016/j.bbrc.2009.02.022.", "ArticleIdList": ["10.1016/j.bbrc.2009.02.022", "19351605"]}, {"Citation": "Finch C.E. Developmental origins of aging in brain and blood vessels: An overview. Neurobiol. Aging. 2005;26:281\u2013291. doi: 10.1016/j.neurobiolaging.2004.03.015.", "ArticleIdList": ["10.1016/j.neurobiolaging.2004.03.015", "15639305"]}, {"Citation": "Caruso C., Lio D., Cavallone L., Franceschi C. Aging, longevity, inflammation, and cancer. Ann. N. Y. Acad. Sci. 2004;1028:1\u201313. doi: 10.1196/annals.1322.001.", "ArticleIdList": ["10.1196/annals.1322.001", "15915584"]}, {"Citation": "Cahill M.R., Perry I.J. Inflammation, aspirin, and the risk of cardiovascular disease. N. Engl. J. Med. 1997;337:422\u2013423.", "ArticleIdList": ["9244847"]}, {"Citation": "Zarev Y., Marinov L., Momekova D., Ionkova I. Exploring phytochemical composition and in vivo anti-inflammatory potential of grape seed oil from an alternative source after traditional fermentation processes: Implications for phytotherapy. Plants. 2023;12:2795. doi: 10.3390/plants12152795.", "ArticleIdList": ["10.3390/plants12152795", "PMC10421439", "37570949"]}, {"Citation": "Grigore A., Vulturescu V., Neagu G., Ungureanu P., Panteli M., Rasit I. Antioxidant\u2013anti-inflammatory evaluation of a polyherbal formula. Pharmaceuticals. 2022;15:114. doi: 10.3390/ph15020114.", "ArticleIdList": ["10.3390/ph15020114", "PMC8874475", "35215227"]}, {"Citation": "Ashton J.C. Cannabinoids for the treatment of inflammation. Curr. Opin. Investig. Drugs. 2007;8:373\u2013384.", "ArticleIdList": ["17520866"]}, {"Citation": "Marsh D.T., Sugiyama A., Imai Y., Kato R., Smid S.D. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid \u03b2-evoked neurotoxicity and changes in cell morphology in PC12 cells. Basic Clin. Pharmacol. Toxicol. 2023 doi: 10.1111/bcpt.13943. online ahead of print .", "ArticleIdList": ["10.1111/bcpt.13943", "37697481"]}, {"Citation": "Pollastro F., Caprioglio D., Del Prete D. Cannabichromene. Nat. Prod. Commun. 2018;13:1934578X1801300922. doi: 10.1177/1934578X1801300922.", "ArticleIdList": ["10.1177/1934578X1801300922"]}, {"Citation": "Huntsman R.J., Tang-Wai R., Alcorn J., Vuong S., Acton B., Corley S., Laprairie R., Lyon A.W., Meier S., Mousseau D.D., et al. Dosage related efficacy and tolerability of cannabidiol in children with treatment-resistant epileptic encephalopathy: Preliminary results of the CARE-E study. Front. Neurol. 2019;10:716. doi: 10.3389/fneur.2019.00716.", "ArticleIdList": ["10.3389/fneur.2019.00716", "PMC6616248", "31333569"]}, {"Citation": "DeLong G.T., Wolf C.E., Poklis A., Lichtman A.H. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by \u03949-tetrahydrocannabinol. Drug Alcohol Depend. 2010;112:126\u2013133. doi: 10.1016/j.drugalcdep.2010.05.019.", "ArticleIdList": ["10.1016/j.drugalcdep.2010.05.019", "PMC2967639", "20619971"]}, {"Citation": "Turner C.E., Elsohly M.A. Biological activity of cannabichromene, its homologs and isomers. J. Clin. Pharmacol. 1981;21 (Supp S1):283S\u2013291S. doi: 10.1002/j.1552-4604.1981.tb02606.x.", "ArticleIdList": ["10.1002/j.1552-4604.1981.tb02606.x", "7298870"]}, {"Citation": "Tortolani D., Di Meo C., Standoli S., Ciaramellano F., Kadhim S., Hsu E., Rapino C., Maccarrone M. Rare phytocannabinoids exert anti-inflammatory effects on human keratinocytes via the endocannabinoid system and MAPK signaling pathway. Int. J. Mol. Sci. 2023;24:2721. doi: 10.3390/ijms24032721.", "ArticleIdList": ["10.3390/ijms24032721", "PMC9917187", "36769042"]}, {"Citation": "Glivar T., Er\u017een J., Kreft S., Zago\u017een M., \u010cerenak A., \u010ceh B., Benkovi\u0107 E.T. Cannabinoid content in industrial hemp (Cannabis sativa L.) varieties grown in Slovenia. Ind. Crops Prod. 2022;145:112082. doi: 10.1016/j.indcrop.2019.112082.", "ArticleIdList": ["10.1016/j.indcrop.2019.112082"]}, {"Citation": "Lim J.D. Cannabis sativa Isolate KNU-18-1 (Cultivar: Pink Pepper), Whole Genome Sequencing Project, GenBank.  [(accessed on 13 March 2023)];2022  Available online:  https://www.ncbi.nlm.nih.gov/datasets/genome/GCA_029168945.1/"}, {"Citation": "Lim J.D. This Research Was Supported by the Ministry of Science and ICT (MSIT, Korea), (Project No.: 2021-DD-UP-0379), figshare. Dataset. 2022.  [(accessed on 13 March 2023)].  Available online:  https://figshare.com/articles/dataset/This_research_was_supported_by_the_Ministry_of_Science_and_ICT_MSIT_Korea_Project_No_2021-DD-UP-0379_/21391449/1."}, {"Citation": "Calcaterra A., Cianfoni G., Tortora C., Manetto S., Grassi G., Botta B., Gasparrini F., Mazzoccanti G., Appendino G. Natural cannabichromene (CBC) shows distinct scalemicity grades and enantiomeric dominance in Cannabis sativa strains. J. Nat. Prod. 2023;86:909\u2013914. doi: 10.1021/acs.jnatprod.2c01139.", "ArticleIdList": ["10.1021/acs.jnatprod.2c01139", "PMC10152484", "37023389"]}, {"Citation": "Mackie K. Cannabinoid receptors: Where they are and what they do. J. Neuroendocrinol. 2008;20:10\u201314. doi: 10.1111/j.1365-2826.2008.01671.x.", "ArticleIdList": ["10.1111/j.1365-2826.2008.01671.x", "18426493"]}, {"Citation": "Onaivi E.S., Ishiguro H., GONG J.P., Patel S., Perchuk A., Meozzi P.A., Myers L., Mora Z., Tagliaferro P., Gardner E., et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. N. Y. Acad. Sci. 2006;1074:514\u2013536. doi: 10.1196/annals.1369.052.", "ArticleIdList": ["10.1196/annals.1369.052", "17105950"]}, {"Citation": "Peyravian N., Deo S., Daunert S., Jimenez J.J. Cannabidiol as a novel therapeutic for immune modulation. ImmunoTargets Ther. 2020;9:131\u2013140. doi: 10.2147/ITT.S263690.", "ArticleIdList": ["10.2147/ITT.S263690", "PMC7445536", "32903924"]}, {"Citation": "Udoh M., Santiago M., Devenish S., McGregor I.S., Connor M. Cannabichromene is a cannabinoid CB2 receptor agonist. Br. J. Pharmacol. 2019;176:4537\u20134547. doi: 10.1111/bph.14815.", "ArticleIdList": ["10.1111/bph.14815", "PMC6932936", "31368508"]}, {"Citation": "Walsh K.B., Holmes A.E. Pharmacology of minor cannabinoids at the cannabinoid CB1 receptor: Isomer-and ligand-dependent antagonism by tetrahydrocannabivarin. Receptors. 2022;1:3\u201312. doi: 10.3390/receptors1010002.", "ArticleIdList": ["10.3390/receptors1010002"]}, {"Citation": "Peng J., Fan M., An C., Ni F., Huang W., Luo J. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD) Basic Clin. Pharmacol. Toxicol. 2022;130:439\u2013456. doi: 10.1111/bcpt.13710.", "ArticleIdList": ["10.1111/bcpt.13710", "35083862"]}, {"Citation": "Khorasani M.M., Hassanshahi G., Brodzikowska A., Khorramdelazad H. Role (s) of cytokines in pulpitis: Latest evidence and therapeutic approaches. Cytokine. 2020;126:154896. doi: 10.1016/j.cyto.2019.154896.", "ArticleIdList": ["10.1016/j.cyto.2019.154896", "31670007"]}, {"Citation": "Lechner M., Lirk P., Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: The two sides of the same coin. Semin. Cancer Biol. 2005;15:277\u2013289. doi: 10.1016/j.semcancer.2005.04.004.", "ArticleIdList": ["10.1016/j.semcancer.2005.04.004", "15914026"]}, {"Citation": "Tanaka T., Narazaki M., Kishimoto T. Interleukin (IL-6) immunotherapy. Cold Spring Harb. Perspect. Biol. 2018;10:a028456. doi: 10.1101/cshperspect.a028456.", "ArticleIdList": ["10.1101/cshperspect.a028456", "PMC6071487", "28778870"]}, {"Citation": "Gliozzi M., Scicchitano M., Bosco F., Musolino V., Carresi C., Scarano F., Maiuolo J., Nucera S., Maretta A., Paone S., et al. Modulation of nitric oxide synthases by oxidized LDLs: Role in vascular inflammation and atherosclerosis development. Int. J. Mol. Sci. 2019;20:3294. doi: 10.3390/ijms20133294.", "ArticleIdList": ["10.3390/ijms20133294", "PMC6651385", "31277498"]}, {"Citation": "Bresalier R.S., Sandler R.S., Quan H., Bolognese J.A., Oxenius B., Horgan K., Lines C., Riddell R., Morton D., Lanas A., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med. 2005;352:1092\u20131102. doi: 10.1056/NEJMoa050493.", "ArticleIdList": ["10.1056/NEJMoa050493", "15713943"]}, {"Citation": "Greenhough A., Smartt H.J., Moore A.E., Roberts H.R., Williams A.C., Paraskeva C., Kaidi A. The COX-2/PGE 2 pathway: Key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009;30:377\u2013386. doi: 10.1093/carcin/bgp014.", "ArticleIdList": ["10.1093/carcin/bgp014", "19136477"]}, {"Citation": "Tak P.P., Firestein G.S. NF-\u03baB: A key role in inflammatory diseases. J. Clin. Investig. 2011;107:7\u201311. doi: 10.1172/JCI11830.", "ArticleIdList": ["10.1172/JCI11830", "PMC198552", "11134171"]}, {"Citation": "Kim J.C., Lee Y.H., Yu M.K., Lee N.H., Park J.D., Bhattarai G., Yi H.K. Anti-inflammatory mechanism of PPAR\u03b3 on LPS-induced pulp cells: Role of the ROS removal activity. Arch. Oral Biol. 2012;57:392\u2013400. doi: 10.1016/j.archoralbio.2011.09.009.", "ArticleIdList": ["10.1016/j.archoralbio.2011.09.009", "21996491"]}, {"Citation": "Lee Y.H., Lee N.H., Bhattarai G., Kim G.E., Lee I.K., Yun B.S., Hwang P.H., Yi H.K. Anti-inflammatory effect of pachymic acid promotes odontoblastic differentiation via HO-1 in dental pulp cells. Oral Dis. 2013;19:193\u2013199. doi: 10.1111/j.1601-0825.2012.01970.x.", "ArticleIdList": ["10.1111/j.1601-0825.2012.01970.x", "22849812"]}, {"Citation": "Morales P., Hurst D.P., Reggio P.H. Molecular targets of the phytocannabinoids: A complex picture. Prog. Chem. Org. Nat. Prod. 2017;103:103\u2013131.", "ArticleIdList": ["PMC5345356", "28120232"]}, {"Citation": "Turner S.E., Williams C.M., Iversen L., Whalley B.J. Molecular pharmacology of phytocannabinoids. Prog. Chem. Org. Nat. Prod. 2017;103:61\u2013101.", "ArticleIdList": ["28120231"]}, {"Citation": "Powles T., Poele R.T., Shamash J., Chaplin T., Propper D., Joel S., Oliver T., Liu W.M. Cannabis-induced cytotoxicity in leukemic cell lines: The role of the cannabinoid receptors and the MAPK pathway. Blood. 2005;105:1214\u20131221. doi: 10.1182/blood-2004-03-1182.", "ArticleIdList": ["10.1182/blood-2004-03-1182", "15454482"]}, {"Citation": "Tedesco L., Valerio A., Dossena M., Cardile A., Ragni M., Pagano C., Pagotto U., Carruba M.O., Vettor R., Nisoli E. Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: The role of eNOS, p38 MAPK, and AMPK pathways. Diabetes. 2010;59:2826\u20132836. doi: 10.2337/db09-1881.", "ArticleIdList": ["10.2337/db09-1881", "PMC2963541", "20739683"]}, {"Citation": "Turu G., Hunyady L. Signal transduction of the CB1 cannabinoid receptor. J. Mol. Endocrinol. 2010;44:75\u201385. doi: 10.1677/JME-08-0190.", "ArticleIdList": ["10.1677/JME-08-0190", "19620237"]}, {"Citation": "Do Y., McKallip R.J., Nagarkatti M., Nagarkatti P.S. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-\u03baB-dependent apoptosis: Novel role for endogenous and exogenous cannabinoids in immunoregulation. J. Immunol. 2004;173:2373\u20132382. doi: 10.4049/jimmunol.173.4.2373.", "ArticleIdList": ["10.4049/jimmunol.173.4.2373", "15294950"]}, {"Citation": "Holland S., Coste O., Zhang D.D., Pierre S.C., Geisslinger G., Scholich K. The ubiquitin ligase MYCBP2 regulates transient receptor potential vanilloid receptor 1 (TRPV1) internalization through inhibition of p38 MAPK signaling. J. Biol. Chem. 2011;286:3671\u20133680. doi: 10.1074/jbc.M110.154765.", "ArticleIdList": ["10.1074/jbc.M110.154765", "PMC3030370", "21098484"]}, {"Citation": "Huang K.F., Ma K.H., Liu P.S., Chen B.W., Chueh S.H. Baicalein increases keratin 1 and 10 expression in hacat keratinocytes via trpv 4 receptor activation. Exp. Dermatol. 2016;25:623\u2013629. doi: 10.1111/exd.13024.", "ArticleIdList": ["10.1111/exd.13024", "27060689"]}, {"Citation": "Xie C., Kang J., Li Z., Schauss A.G., Badger T.M., Nagarajan S., Wu T., Wu X. The a\u00e7a\u00ed flavonoid velutin is a potent anti-inflammatory agent: Blockade of LPS-mediated TNF-\u03b1 and IL-6 production through inhibiting NF-\u03baB activation and MAPK pathway. J. Nutr. Biochem. 2012;23:1184\u20131191. doi: 10.1016/j.jnutbio.2011.06.013.", "ArticleIdList": ["10.1016/j.jnutbio.2011.06.013", "22137267"]}, {"Citation": "Sun P., Zhou K., Wang S., Li P., Chen S., Lin G., Zhao Y., Wang T. Involvement of MAPK/NF-\u03baB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation. PLoS ONE. 2013;8:e69424. doi: 10.1371/journal.pone.0069424.", "ArticleIdList": ["10.1371/journal.pone.0069424", "PMC3732220", "23936328"]}, {"Citation": "Myers M.J., Deaver C.M., Lewandowski A.J. Molecular mechanism of action responsible for carrageenan-induced inflammatory response. Mol. Immunol. 2019;109:38\u201342. doi: 10.1016/j.molimm.2019.02.020.", "ArticleIdList": ["10.1016/j.molimm.2019.02.020", "30851635"]}, {"Citation": "Halici Z., Dengiz G.O., Odabasoglu F., Suleyman H., Cadirci E., Halici M. Amiodarone has anti-inflammatory and anti-oxidative properties: An experimental study in rats with carrageenan-induced paw edema. Eur. J. Pharmacol. 2007;566:215\u2013221. doi: 10.1016/j.ejphar.2007.03.046.", "ArticleIdList": ["10.1016/j.ejphar.2007.03.046", "17475238"]}, {"Citation": "Burayk S., Oh-Hashi K., Kandeel M. Drug discovery of new anti-inflammatory compounds by targeting cyclooxygenases. Pharmaceuticals. 2022;15:282. doi: 10.3390/ph15030282.", "ArticleIdList": ["10.3390/ph15030282", "PMC8955829", "35337080"]}, {"Citation": "Kasama T., Miwa Y., Isozaki T., Odai T., Adachi M., Kunkel S.L. Neutrophil-derived cytokines: Potential therapeutic targets in inflammation. Curr. Drug Targets Inflamm. Allergy. 2005;4:273\u2013279. doi: 10.2174/1568010054022114.", "ArticleIdList": ["10.2174/1568010054022114", "16101533"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "10", "Day": "23"}, {"Year": "2023", "Month": "11", "Day": "17"}, {"Year": "2023", "Month": "11", "Day": "21"}, {"Year": "2023", "Month": "12", "Day": "9", "Hour": "10", "Minute": "45"}, {"Year": "2023", "Month": "12", "Day": "9", "Hour": "10", "Minute": "44"}, {"Year": "2023", "Month": "12", "Day": "9", "Hour": "1", "Minute": "11"}, {"Year": "2023", "Month": "11", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["38068603", "PMC10708362", "10.3390/plants12233966", "plants12233966"]}}], "PubmedBookArticle": []}